impact factor
logo
 

One year in review

 

One year in review 2020: vasculitis


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12

 

  1. Rheumatology Unit, Department of Medicine-DIMED, University of Padova, Italy.
  2. Clinic of Rheumatology, Department of Medicine, University of Udine, Italy.
  3. Department of Surgical, Medical, Molecular Pathology and of Critical Area, University of Pisa, Italy.
  4. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  5. Rheumatology Unit, S. Chiara Hospital, Trento, Italy.
  6. Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia; and University of Pavia, PhD in Experimental Medicine, Pavia, Italy.
  7. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, and Department of Medical Biotechnologies, University of Siena, Italy.
  8. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  9. Department of Rheumatology, University of Pavia, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy.
  10. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  11. Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
  12. Clinic of Rheumatology, Department of Medicine, University of Udine, Italy. luca.quartuccio@asuiud.sanita.fvg.it

CER13412
2020 Vol.38, N°2 ,Suppl.124
PI 0003, PF 0014
One year in review

Free to view
(click on article PDF icon to read the article)

PMID: 32359039 [PubMed]

Received: 06/04/2020
Accepted : 19/04/2020
In Press: 28/04/2020
Published: 21/05/2020

Abstract

Systemic vasculitides are a group of diseases that could potentially affect any organ with heterogeneous clinical manifestations that usually depend on the size of the most involved vessels. These diseases could be associated with a relevant burden of mortality and morbidity if not early recognised and treated. Moreover, even if they are usually rare diseases, their incidence and prevalence seem to be increasing in the last decade, partially because of improved awareness and management of vasculitis from physicians. Like in the previous annual reviews of this series, in this paper we revised the most recent literature on pathogenesis, clinical manifestations and treatment options in small- and large-vessel vasculitis.

Rheumatology Article